These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 4025118)

  • 1. Analysis of the efficacy of the new cardiotonic agent TA-064.
    Thormann J; Kramer W; Kindler M; Neuss H; Bahawar H; Schlepper M
    Am Heart J; 1985 Aug; 110(2):426-38. PubMed ID: 4025118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of the new cardiotonic agent TA-064: serial computer-assisted analyses of pressure-volume relations and online myocardial 02 consumption].
    Thormann J; Kramer W; Kindler M; Neuss H; Bahawar H; Schlepper M
    Z Kardiol; 1984 Dec; 73(12):772-85. PubMed ID: 6523977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacy of the new cardiotonic agent DPI 201-106 versus dobutamine in dilated cardiomyopathy: analysis by serial pressure/volume relations and "on-line" MVO2 assessment.
    Thormann J; Kramer W; Kindler M; Kremer FP; Schlepper M
    J Cardiovasc Pharmacol; 1986; 8(4):749-57. PubMed ID: 2427814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular effects and plasma levels of denopamine (TA-064), a new positive inotropic agent, in chronically instrumented dogs.
    Ikeo T; Nagao T; Suzuki T; Yabana H; Nakajima H
    Jpn J Pharmacol; 1985 Oct; 39(2):191-9. PubMed ID: 4087566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of denopamine (TA-064), a new positive inotropic agent, on myocardial oxygen consumption and left ventricular dimension in anesthetized dogs.
    Ikeo T; Nagao T
    Jpn J Pharmacol; 1985 Oct; 39(2):179-89. PubMed ID: 4087565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopharmacological studies of a newly synthesized cardiotonic agent (TA-064) in patients with congestive heart failure.
    Bito K; Kinoshita M; Mashiro I; Ozaki N; Sakoda S; Tsutamoto T; Motomura M; Mitsunami K; Fukuhara T; Kawakita S
    Clin Cardiol; 1988 May; 11(5):334-9. PubMed ID: 3383472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contractile, coronary, and metabolic effects of the acute and long-term treatment of cardiac failure with prenalterol.
    Strauer BE; Bohn I; Hahn B; Kment A; Motz U
    J Cardiovasc Pharmacol; 1984; 6(3):491-8. PubMed ID: 6202977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular geometry, myocardial function and energetics of the dilated left ventricle. Influence of vasodilators and positive inotropic substances.
    Holubarsch C; Hasenfuss G; Thierfelder L; Just H
    Herz; 1991 Sep; 16 Spec No 1():298-303. PubMed ID: 1820296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of commonly used inotropes on myocardial function and oxygen consumption under constant ventricular loading conditions.
    DeWitt ES; Black KJ; Thiagarajan RR; DiNardo JA; Colan SD; McGowan FX; Kheir JN
    J Appl Physiol (1985); 2016 Jul; 121(1):7-14. PubMed ID: 27150829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular effects of a newly synthesized cardiotonic agent (TA-064) on normal and diseased hearts.
    Kino M; Hirota Y; Yamamoto S; Sawada K; Moriguchi M; Kotaka M; Kubo S; Kawamura K
    Am J Cardiol; 1983 Mar; 51(5):802-10. PubMed ID: 6829441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dose-dependent effect of amrinone on hemodynamics, myocardial circulation and myocardial energy requirement. An experimental study].
    Veit S; Brückner JB; Vogt K; Wagner R; Hess W
    Z Kardiol; 1985 Feb; 74(2):76-84. PubMed ID: 3993153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?].
    Günnicker M; Brinkmann M; Freund U; Piotrowski J; Schieffer M; Velser U
    Herz; 1995 Dec; 20(6):399-411. PubMed ID: 8582699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic effects of intravenous butopamine in congestive heart failure.
    Thompson MJ; Huss P; Unverferth DV; Fasola A; Leier CV
    Clin Pharmacol Ther; 1980 Sep; 28(3):324-34. PubMed ID: 7408391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Reduction in left ventricular volume and improvement in hemodynamics following intravenous administration of pimobendan (UDGG 115 BS) in dilated cardiomyopathy].
    Permanetter B; Sebening H; Busch U; Lutilsky L
    Z Kardiol; 1990 Aug; 79(8):565-72. PubMed ID: 2220013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel inotropic vasodilator, OPC-18790, reduces myocardial oxygen consumption and improves mechanical efficiency with congestive heart failure.
    Kanda H; Yokota M; Ishihara H; Nagata K; Kato R; Sobue T
    Am Heart J; 1996 Aug; 132(2 Pt 1):361-8. PubMed ID: 8701899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the role of the renin-angiotensin system in cardiac contractility utilizing the renin inhibitor remikiren.
    van Kats JP; Sassen LM; Danser AH; Polak MP; Soei LK; Derkx FH; Schalekamp MA; Verdouw PD
    Br J Pharmacol; 1996 Mar; 117(5):891-901. PubMed ID: 8851507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic profile of the cardiotonic agent pimobendan.
    van Meel JC; Diederen W
    J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S1-6. PubMed ID: 2478784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of MCI-154, a cardiotonic agent, on regional contractile function and myocardial oxygen consumption in the presence and absence of coronary artery stenosis in dogs.
    Abe Y; Kitada Y; Narimatsu A
    J Pharmacol Exp Ther; 1993 May; 265(2):819-25. PubMed ID: 8496827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic and myocardial energetic changes induced by the new cardiotonic agent, AR-L 115, in patients with coronary artery disease.
    Thormann J; Kramer W; Schlepper M
    Am Heart J; 1982 Dec; 104(6):1294-302. PubMed ID: 7148647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of toborinone on myocardial oxygen consumption in pacing-induced heart failure dogs.
    Itoh S; Mori T; Fujiki H; Tominaga M
    Arzneimittelforschung; 1996 Dec; 46(12):1105-9. PubMed ID: 9006782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.